Potential Roles of Cellular Senescence and Inflammaging in Prostate Cancer: Aging Microenvironment, Immune Remodeling, and Therapeutic Implications
Cells · 13.08.2026 · 15 (16) · 1457
DOI: 10.3390/cells15161457 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 13.08.2026. Verfasst von Qiuyang Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Cellular Senescence, Tumor Microenvironment, Inflammation. Die Arbeit nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Prostate cancer is common in older men, yet mechanisms linking aging to tumor progression remain incompletely defined. Beyond genetic alterations, aging reshapes the prostate microenvironment through cellular senescence, chronic low-grade inflammation, immune dysfunction, stromal remodeling, metabolic stress, and impaired tissue repair, collectively promoting inflammaging. This persistent inflammatory state may create a permissive niche for tumor initiation, progression, immune evasion, and treatment resistance. Senescent epithelial and stromal cells release cytokines, chemokines, growth factors, matrix-remodeling enzymes, and extracellular vesicles through the senescence-associated secretory phenotype (SASP). In parallel, immune aging alters T-cell subsets, myeloid cells, macrophages, and anti-tumor surveillance. This review summarizes how SASP programs, Th17/Treg imbalance, IL-17/IL-23 signaling, myeloid remodeling, stromal aging, metabolic stress, and immune–stromal–epithelial crosstalk shape prostate cancer biology. We further discuss therapeutic implications, including cytokine modulation, senescence-directed therapy, metabolic intervention, and biomarker-guided strategies. This review highlights key knowledge gaps and proposes a framework for age-aware prostate cancer research, biomarker development, and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Structural and Cellular Biology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
ORCID-Profile: Qiuyang Zhang
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Zhang, Q., Shen, K., & Liu, S. (2026). Potential Roles of Cellular Senescence and Inflammaging in Prostate Cancer: Aging Microenvironment, Immune Remodeling, and Therapeutic Implications. Cells, 15(16), 1457. https://doi.org/10.3390/cells15161457
Vancouver
Zhang Q, Shen K, Liu S. Potential Roles of Cellular Senescence and Inflammaging in Prostate Cancer: Aging Microenvironment, Immune Remodeling, and Therapeutic Implications. Cells. 2026;15(16):1457. doi:10.3390/cells15161457
BibTeX
@article{Zhang2026,
author = {Zhang, Qiuyang and Shen, Keyi and Liu, Sen},
title = {Potential Roles of Cellular Senescence and Inflammaging in Prostate Cancer: Aging Microenvironment, Immune Remodeling, and Therapeutic Implications},
journal = {Cells},
year = {2026},
volume = {15},
number = {16},
pages = {1457},
doi = {10.3390/cells15161457}
}
EUVIMED